Tsuburaya, Akira http://orcid.org/0000-0002-7931-8171
Guan, Jia
Yoshida, Kazuhiro
Kobayashi, Michiya
Yoshino, Shigefumi
Tanabe, Kazuaki
Yoshikawa, Takaki
Oshima, Takashi
Miyashita, Yumi
Sakamoto, Junichi
Tanaka, Shiro
Funding for this research was provided by:
Project Promoting Clinical Trials for Development of New Drugs (20lk0201061t0005)
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy (20lk0201061t0005)
Article History
Received: 13 December 2020
Accepted: 1 August 2021
First Online: 7 August 2021
Declarations
:
: JG: research funds from the Japan Agency for Medical Research and Development., outside the submitted work KY: grants and personal fees from Taiho Pharm, Asahi Kasei Pharma, Chugai Pharm., Covidien Japan, Daiichi Sankyo, Eisai, Eli Lilly Japan, Johnson & Johnson, MerkSerono, MSD, Nippon Kayaku, Novartis, Ono Pharm., Otsuka Pharm., Sanofi, Takeda Pharm., Tsumura, Yakult Honsha,; grants from Abbott, Abbvie, Astellas, Biogen Japan, Celgene, GlaxoSmithKline, KCI, Koninklijke Philips, Kyowa Kirin, Meiji Seika Pharma, Toray Medical,; personal fees from AstraZeneka, Bristol-Myers Squibb, Denka, EA Pharma, Olympus, Pfizer, Sanwa Kagaku Kenkyusho, SBI Pharma, Teijin Pharma, TERUMO, outside the submitted work. TS: Lecture fee from Taiho, Chugai, MSD, ONO, BMS, Lilly, and Pfizer. Grant from Lilly. TO: Research Funding: Taiho pharmaceutical Co., Ltd, Chugai pharmaceutical Co., Ltd, Ono pharmaceutical Co., Ltd, Daiichi-Sankyo pharmaceutical, Nippon Kayaku Co., Ltd, and Eli Lilly Japan K. K. Lecture fees: Nippon Kayaku Co., Ltd, Ono pharmaceutical Co., Ltd and Bristol-Myers Squibb K. K. Speaker Bureau: Taiho pharmaceutical Co., Ltd, Chugai pharmaceutical Co., Ltd, Ono pharmaceutical Co., Ltd, Bristol-Myers Squibb K. K and Eli Lilly Japan K. K. These are unrelated to the submitted work. ST: lecture fee from Bayer Yakuhin, Amgen Astellas BioPharma K.K. and Research Institute of Healthcare Data Science. Consultation fee from Boehringer Ingelheim and Satt. Outsourcing fee from Public Health Research Foundation. Research funds from the Japan Agency for Medical Research and Development, the Japanese Ministry of Health Labor and Welfare, the Japanese Ministry of Education, Science, and Technology, and Novo Nordisk. Engaged in a research project of the Japan Agency for Medical Research and Development.
Free to read: This content has been made available to all.